These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

729 related articles for article (PubMed ID: 26510686)

  • 1. Exploring DNA methylation changes in promoter, intragenic, and intergenic regions as early and late events in breast cancer formation.
    Rauscher GH; Kresovich JK; Poulin M; Yan L; Macias V; Mahmoud AM; Al-Alem U; Kajdacsy-Balla A; Wiley EL; Tonetti D; Ehrlich M
    BMC Cancer; 2015 Oct; 15():816. PubMed ID: 26510686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypermethylation of CDKN2A exon 2 in tumor, tumor-adjacent and tumor-distant tissues from breast cancer patients.
    Spitzwieser M; Entfellner E; Werner B; Pulverer W; Pfeiler G; Hacker S; Cichna-Markl M
    BMC Cancer; 2017 Apr; 17(1):260. PubMed ID: 28403857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CpG promoter methylation of the ALKBH3 alkylation repair gene in breast cancer.
    Stefansson OA; Hermanowicz S; van der Horst J; Hilmarsdottir H; Staszczak Z; Jonasson JG; Tryggvadottir L; Gudjonsson T; Sigurdsson S
    BMC Cancer; 2017 Jul; 17(1):469. PubMed ID: 28679371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mapping geographic zones of cancer risk with epigenetic biomarkers in normal breast tissue.
    Yan PS; Venkataramu C; Ibrahim A; Liu JC; Shen RZ; Diaz NM; Centeno B; Weber F; Leu YW; Shapiro CL; Eng C; Yeatman TJ; Huang TH
    Clin Cancer Res; 2006 Nov; 12(22):6626-36. PubMed ID: 17121881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single CpG hypermethylation, allele methylation errors, and decreased expression of multiple tumor suppressor genes in normal body cells of mutation-negative early-onset and high-risk breast cancer patients.
    Böck J; Appenzeller S; Haertle L; Schneider T; Gehrig A; Schröder J; Rost S; Wolf B; Bartram CR; Sutter C; Haaf T
    Int J Cancer; 2018 Sep; 143(6):1416-1425. PubMed ID: 29659014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genome-wide methylation profiling identified novel differentially hypermethylated biomarker MPPED2 in colorectal cancer.
    Gu S; Lin S; Ye D; Qian S; Jiang D; Zhang X; Li Q; Yang J; Ying X; Li Z; Tang M; Wang J; Jin M; Chen K
    Clin Epigenetics; 2019 Mar; 11(1):41. PubMed ID: 30846004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene methylation in gastric cancer.
    Qu Y; Dang S; Hou P
    Clin Chim Acta; 2013 Sep; 424():53-65. PubMed ID: 23669186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptional implications of intragenic DNA methylation in the oestrogen receptor alpha gene in breast cancer cells and tissues.
    Shenker NS; Flower KJ; Wilhelm-Benartzi CS; Dai W; Bell E; Gore E; El Bahrawy M; Weaver G; Brown R; Flanagan JM
    BMC Cancer; 2015 May; 15():337. PubMed ID: 25927974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An integrated genomics analysis of epigenetic subtypes in human breast tumors links DNA methylation patterns to chromatin states in normal mammary cells.
    Holm K; Staaf J; Lauss M; Aine M; Lindgren D; Bendahl PO; Vallon-Christersson J; Barkardottir RB; Höglund M; Borg Å; Jönsson G; Ringnér M
    Breast Cancer Res; 2016 Feb; 18(1):27. PubMed ID: 26923702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aging related methylation influences the gene expression of key control genes in colorectal cancer and adenoma.
    Galamb O; Kalmár A; Barták BK; Patai ÁV; Leiszter K; Péterfia B; Wichmann B; Valcz G; Veres G; Tulassay Z; Molnár B
    World J Gastroenterol; 2016 Dec; 22(47):10325-10340. PubMed ID: 28058013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.
    Yuan J; Luo RZ; Fujii S; Wang L; Hu W; Andreeff M; Pan Y; Kadota M; Oshimura M; Sahin AA; Issa JP; Bast RC; Yu Y
    Cancer Res; 2003 Jul; 63(14):4174-80. PubMed ID: 12874023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enrichment of CpG island shore region hypermethylation in epigenetic breast field cancerization.
    Muse ME; Titus AJ; Salas LA; Wilkins OM; Mullen C; Gregory KJ; Schneider SS; Crisi GM; Jawale RM; Otis CN; Christensen BC; Arcaro KF
    Epigenetics; 2020 Oct; 15(10):1093-1106. PubMed ID: 32255732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic Changes of the ESR1 Gene in Breast Tissue of Healthy Women: A Missing Link with Breast Cancer Risk Factors?
    Daraei A; Izadi P; Khorasani G; Nafissi N; Naghizadeh MM; Younosi N; Meysamie A; Mansoori Y; Bastami M; Tavakkoly-Bazzaz J
    Genet Test Mol Biomarkers; 2017 Aug; 21(8):464-470. PubMed ID: 28708432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Promoter hypermethylation of the tumor-suppressor genes RASSF1A, GSTP1 and CDH1 in endometrial cancer.
    Fiolka R; Zubor P; Janusicova V; Visnovsky J; Mendelova A; Kajo K; Lasabova Z; Plank L; Danko J
    Oncol Rep; 2013 Dec; 30(6):2878-86. PubMed ID: 24068440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Large-scale analysis of
    Croes L; Beyens M; Fransen E; Ibrahim J; Vanden Berghe W; Suls A; Peeters M; Pauwels P; Van Camp G; Op de Beeck K
    Clin Epigenetics; 2018; 10():51. PubMed ID: 29682089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genome-wide DNA methylation analysis reveals molecular subtypes of pancreatic cancer.
    Mishra NK; Guda C
    Oncotarget; 2017 Apr; 8(17):28990-29012. PubMed ID: 28423671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequent epigenetic inactivation of RSK4 by promoter methylation in cancerous and non-cancerous tissues of breast cancer.
    Li Q; Jiang Y; Wei W; Ji Y; Gao H; Liu J
    Med Oncol; 2014 Jan; 31(1):793. PubMed ID: 24338215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypomethylation coordinates antagonistically with hypermethylation in cancer development: a case study of leukemia.
    Kushwaha G; Dozmorov M; Wren JD; Qiu J; Shi H; Xu D
    Hum Genomics; 2016 Jul; 10 Suppl 2(Suppl 2):18. PubMed ID: 27461342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploring breast carcinogenesis through integrative genomics and epigenomics analyses.
    Minning C; Mokhtar NM; Abdullah N; Muhammad R; Emran NA; Ali SA; Harun R; Jamal R
    Int J Oncol; 2014 Nov; 45(5):1959-68. PubMed ID: 25175708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor suppressor gene promoter hypermethylation in serum of breast cancer patients.
    Dulaimi E; Hillinck J; Ibanez de Caceres I; Al-Saleem T; Cairns P
    Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6189-93. PubMed ID: 15448006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.